Trial intelligence / Profile preview

Xuebi Prescription in Diabetic Peripheral Neuropathy

NCT02039544Unknown

Sponsor
Guang'anmen Hospital
Start
Jan 2014
Primary completion
Jan 2015
Modality
Botanical Extract
01

Overview

Randomised, double-blind trial in diabetic peripheral neuropathy (DPN) comparing Xuebi formula with Placebo (2 arms). Primary endpoints: Toronto Clinical Scoring System at 24 weeks and Traditional Chinese Medicine clinical symptom score at 24 weeks. Status: unknown.

02

Drugs

Xuebi Formula
03

Conditions

diabetic peripheral neuropathy (DPN)

Beyond the preview

Go deeper on NCT02039544.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02039544.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call